Annual Shareholders Equity
$3.67 M
-$3.25 M-46.97%
31 December 2023
Summary:
Protagenic Therapeutics annual stockholders equity is currently $3.67 million, with the most recent change of -$3.25 million (-46.97%) on 31 December 2023. During the last 3 years, it has risen by +$4.82 million (+419.05%). PTIX annual shareholders equity is now -93.26% below its all-time high of $54.39 million, reached on 31 December 2008.PTIX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$719.00 K
-$73.50 K-9.27%
30 September 2024
Summary:
Protagenic Therapeutics quarterly stockholders equity is currently $719.00 thousand, with the most recent change of -$73.50 thousand (-9.27%) on 30 September 2024. Over the past year, it has dropped by -$3.43 million (-82.69%). PTIX quarterly shareholders equity is now -99.57% below its all-time high of $165.84 million, reached on 30 June 2008.PTIX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTIX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -47.0% | -82.7% |
| 3 y3 years | +419.1% | -93.1% |
| 5 y5 years | +1839.3% | +297.7% |
PTIX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -63.1% | +419.1% | -93.1% | at low |
| 5 y | 5 years | -63.1% | +419.1% | -93.3% | +136.3% |
| alltime | all time | -93.3% | +121.3% | -99.6% | +112.7% |
Protagenic Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $719.00 K(-9.3%) |
| June 2024 | - | $792.50 K(-62.8%) |
| Mar 2024 | - | $2.13 M(-41.9%) |
| Dec 2023 | $3.67 M(-47.0%) | $3.67 M(-11.7%) |
| Sept 2023 | - | $4.15 M(-23.3%) |
| June 2023 | - | $5.41 M(-15.6%) |
| Mar 2023 | - | $6.41 M(-7.3%) |
| Dec 2022 | $6.92 M(-30.4%) | $6.92 M(-6.3%) |
| Sept 2022 | - | $7.38 M(-10.6%) |
| June 2022 | - | $8.26 M(-5.3%) |
| Mar 2022 | - | $8.72 M(-12.3%) |
| Dec 2021 | $9.94 M(-964.7%) | $9.94 M(-4.1%) |
| Sept 2021 | - | $10.37 M(-4.0%) |
| June 2021 | - | $10.80 M(-644.6%) |
| Mar 2021 | - | -$1.98 M(+72.4%) |
| Dec 2020 | -$1.15 M(+81.2%) | -$1.15 M(+12.6%) |
| Sept 2020 | - | -$1.02 M(+36.8%) |
| June 2020 | - | -$746.10 K(+27.3%) |
| Mar 2020 | - | -$585.90 K(-7.6%) |
| Dec 2019 | -$634.40 K(+200.8%) | -$634.40 K(+74.4%) |
| Sept 2019 | - | -$363.70 K(-4.2%) |
| June 2019 | - | -$379.50 K(+4.9%) |
| Mar 2019 | - | -$361.80 K(+71.6%) |
| Dec 2018 | -$210.90 K(-117.3%) | -$210.90 K(-165.3%) |
| Sept 2018 | - | $323.00 K(-42.3%) |
| June 2018 | - | $559.90 K(-42.0%) |
| Mar 2018 | - | $964.90 K(-20.9%) |
| Dec 2017 | $1.22 M(-50.8%) | $1.22 M(-27.5%) |
| Sept 2017 | - | $1.68 M(-10.3%) |
| June 2017 | - | $1.88 M(-13.8%) |
| Mar 2017 | - | $2.18 M(-12.1%) |
| Dec 2016 | $2.48 M(-598.4%) | $2.48 M(-15.7%) |
| Sept 2016 | - | $2.94 M(-7.8%) |
| June 2016 | - | $3.19 M(+5.6%) |
| Mar 2016 | - | $3.02 M(-483.8%) |
| Dec 2015 | - | -$786.00 K(+25.2%) |
| Sept 2015 | - | -$628.00 K(+26.4%) |
| June 2015 | -$497.00 K(+2266.7%) | -$497.00 K(+29.1%) |
| Mar 2015 | - | -$385.00 K(+44.7%) |
| Dec 2014 | - | -$266.00 K(+100.0%) |
| Sept 2014 | - | -$133.00 K(+533.3%) |
| June 2014 | -$21.00 K(-99.9%) | -$21.00 K(-99.6%) |
| June 2013 | -$17.23 M(-310.8%) | - |
| Sept 2011 | - | -$5.65 M(+407.3%) |
| June 2011 | - | -$1.11 M(-122.6%) |
| Mar 2011 | - | $4.93 M(-39.7%) |
| Dec 2010 | $8.17 M | $8.17 M(-44.3%) |
| Sept 2010 | - | $14.67 M(-18.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | $18.07 M(-18.9%) |
| Mar 2010 | - | $22.29 M(-12.1%) |
| Dec 2009 | $25.35 M(-53.4%) | $25.35 M(-49.0%) |
| Sept 2009 | - | $49.74 M(-3.0%) |
| June 2009 | - | $51.26 M(-2.7%) |
| Mar 2009 | - | $52.70 M(-3.1%) |
| Dec 2008 | $54.39 M(+228.0%) | $54.39 M(-66.9%) |
| Sept 2008 | - | $164.34 M(-0.9%) |
| June 2008 | - | $165.84 M(+0.5%) |
| Mar 2008 | - | $165.05 M(+895.4%) |
| Dec 2007 | $16.58 M(+1255.8%) | $16.58 M(-4.3%) |
| Sept 2007 | - | $17.33 M(-8.2%) |
| June 2007 | - | $18.88 M(-0.6%) |
| Mar 2007 | - | $19.00 M(<-9900.0%) |
| Dec 2006 | $1.22 M(-811.0%) | - |
| Oct 2006 | - | -$27.50 K(-84.0%) |
| July 2006 | - | -$172.00 K(+5.7%) |
| July 2006 | -$172.00 K(+82.0%) | - |
| Apr 2006 | - | -$162.80 K(+5.7%) |
| Jan 2006 | - | -$154.00 K(+8.5%) |
| Oct 2005 | - | -$141.90 K(-101.5%) |
| July 2005 | -$94.50 K(-103.5%) | - |
| July 2004 | $2.74 M(-78.7%) | - |
| Apr 2003 | - | $9.19 M(-2.5%) |
| Jan 2003 | - | $9.43 M(-23.9%) |
| Oct 2002 | - | $12.40 M(-3.7%) |
| July 2002 | $12.87 M(-5.1%) | $12.87 M(-3.4%) |
| Apr 2002 | - | $13.32 M(-1.3%) |
| Jan 2002 | - | $13.50 M(-1.5%) |
| Oct 2001 | - | $13.71 M(+1.1%) |
| July 2001 | $13.57 M(+0.9%) | $13.57 M(-2.3%) |
| Apr 2001 | - | $13.88 M(+0.2%) |
| Jan 2001 | - | $13.86 M(+0.6%) |
| Oct 2000 | - | $13.77 M(+2.5%) |
| July 2000 | $13.44 M(+1.3%) | $13.44 M(+2.2%) |
| Apr 2000 | - | $13.16 M(+1.6%) |
| Jan 2000 | - | $12.94 M(-6.2%) |
| Oct 1999 | - | $13.80 M(+4.0%) |
| July 1999 | $13.27 M(-4.8%) | $13.27 M(-5.9%) |
| Apr 1999 | - | $14.10 M(-1.4%) |
| Jan 1999 | - | $14.30 M(0.0%) |
| Oct 1998 | - | $14.30 M(+2.5%) |
| July 1998 | $13.95 M(+4.9%) | $13.95 M(+0.3%) |
| Apr 1998 | - | $13.90 M(+2.2%) |
| Jan 1998 | - | $13.60 M(+0.7%) |
| Oct 1997 | - | $13.50 M(+1.5%) |
| July 1997 | $13.30 M | $13.30 M(-1.5%) |
| Apr 1997 | - | $13.50 M(-0.7%) |
| Jan 1997 | - | $13.60 M |
FAQ
- What is Protagenic Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Protagenic Therapeutics?
- What is Protagenic Therapeutics annual shareholders equity year-on-year change?
- What is Protagenic Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Protagenic Therapeutics?
- What is Protagenic Therapeutics quarterly shareholders equity year-on-year change?
What is Protagenic Therapeutics annual stockholders equity?
The current annual shareholders equity of PTIX is $3.67 M
What is the all time high annual shareholders equity for Protagenic Therapeutics?
Protagenic Therapeutics all-time high annual stockholders equity is $54.39 M
What is Protagenic Therapeutics annual shareholders equity year-on-year change?
Over the past year, PTIX annual stockholders equity has changed by -$3.25 M (-46.97%)
What is Protagenic Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of PTIX is $719.00 K
What is the all time high quarterly shareholders equity for Protagenic Therapeutics?
Protagenic Therapeutics all-time high quarterly stockholders equity is $165.84 M
What is Protagenic Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, PTIX quarterly stockholders equity has changed by -$3.43 M (-82.69%)